The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 05, 2018

Filed:

Jul. 14, 2016
Applicant:

Modiquest B.v., Oss, NL;

Inventors:
Assignee:

Modiquest B.V., Oss, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 16/28 (2006.01); A61K 39/395 (2006.01); C07K 14/705 (2006.01); A61K 9/00 (2006.01); A61K 51/10 (2006.01); A61K 47/68 (2017.01);
U.S. Cl.
CPC ...
C07K 16/28 (2013.01); A61K 9/0019 (2013.01); A61K 39/39558 (2013.01); A61K 47/6803 (2017.08); A61K 47/6817 (2017.08); A61K 47/6849 (2017.08); A61K 51/1018 (2013.01); C07K 14/705 (2013.01); C07K 2317/22 (2013.01); C07K 2317/569 (2013.01);
Abstract

The present invention relates to plexin D1 for use as a targetable protein in the treatment or diagnosis of disorders that involve expression of plexin D1. Diagnosis is suitably effected by detecting the presence of plexin D1 in the body or a bodily tissue or fluid, whereas treatment is effected by targeting plexin D1 for delivery of therapeutics to the site where treatment is needed. The invention further relates to the use of molecules that bind plexin D1, a nucleic acid encoding plexin D1 or a ligand of plexin D1 for the preparation of a therapeutical composition for the treatment or diagnosis of disorders that involve expression of plexin D1. The disorders comprise disorders in which plexin D1 is expressed on tumor cells, tumor blood vessels or activated macrophages.


Find Patent Forward Citations

Loading…